Pharmaceuticals
Jim Cramer: Panic Has Not Been Contained in This Market
I think, ultimately, the big issue for many will be what happens in the United States if we hear about people who didn't go to China who have come down with the disease.
A Technical Strategy for AbbVie as the Broader Market Gets Rocked
ABBV could bounce today but there remains the risk of a deeper correction.
Regeneron's Pullback Amid Market Weakness Could Lead to Buying Opportunity
The biopharma giant could fall further, so wait for a candlestick reversal pattern before going long.
Coronavirus Spooks the U.S. Markets
Many market players - including me - would be relieved to see a decent bout of selling.
3 Undervalued Stocks That Should Gain Ground in 2020
American Airlines, Supernus Pharmaceuticals and TPI Composites should see their fortunes improve this year.
Abbott Laboratories Could Climb to the $107 Area Next
Barring a negative surprise I would look for higher highs to be established in the days and weeks ahead.
GlaxoSmithKline: The Charts Are Pointing Higher
Our latest analysis and trading strategy for the the big pharma stock.
Biotech's Big Week Finds a Big Winner in Adaptimmune
The clinical stage company sees its shares climb after announcing some significant news during this week's J.P. Morgan Healthcare Conference.
Should You Be Preparing to Supplement Your Portfolio With More CVS Stock?
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
Bristol-Myers Squibb's Stock Could Soar to New All-Time Highs This Quarter
Let's review the charts.